The Armonk campus in Westchester County hosts focused teams in computational biology, data science, and early discovery, leveraging proximity to headquarters for collaborative R&D in AI-driven drug design and genomics analysis.
It enhances Regeneron's innovation through cutting-edge tech integration.
Situated in the Kendall Square biotech hub, the Cambridge campus specializes in gene therapy, RNA therapeutics, and partnerships with academic institutions, advancing next-generation modalities for genetic diseases.
It taps into Boston's talent pool for breakthrough innovations.
The Rensselaer campus is Regeneron's key manufacturing and industrial operations site in the Capital Region, specializing in large-scale production of biologics, process development, and supply chain for commercial medicines. It supports advanced bioprocessing technologies for monoclonal antibodies and fusion proteins.
This campus plays a critical role in scaling Regeneron's discoveries into life-changing treatments, with ongoing expansions to meet growing demand.
The Seattle campus emphasizes immunology and oncology research, leveraging the Pacific Northwest's tech ecosystem for computational and antibody discovery programs.
Expands Regeneron's West Coast presence.
The Sleepy Hollow campus, adjacent to the Tarrytown headquarters, supports specialized research in preclinical development, toxicology, and pathology, contributing to Regeneron's drug discovery pipeline with a focus on safety assessment and translational research.
Integrating seamlessly with Westchester operations, it ensures robust safety data for advancing candidates to clinical stages.
The Tarrytown campus serves as Regeneron's corporate headquarters and primary research and development hub, focusing on pioneering biotechnology innovations to treat serious diseases through advanced genetics, antibody engineering, and therapeutic discovery. This main campus houses core scientific teams driving the company's pipeline in immunology, oncology, and rare diseases.
With state-of-the-art labs and computational platforms, Tarrytown fosters interdisciplinary collaboration, from early discovery to clinical development, positioning Regeneron at the forefront of precision medicine.
The Warren campus focuses on clinical development, medical affairs, and regional operations, supporting late-stage trials and commercialization in immunology and respiratory diseases.
It bridges research and market delivery.
The Washington DC office specializes in government affairs, policy, and regulatory strategy, advocating for biotech innovation and patient access to therapies.
Key for navigating the policy landscape.
